Projects

Impact of calcineurin inhibitor therapy on the course of steroid resistant nephrotic syndrome in children

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2024 - 2025

Project Lead

Dr. Anil Vasudevan

Authors

Dr. Anil Vasudevan, Dr. Nivedita Kamath, Dr. Jimba Jatsho

Project Status

completed